Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 310, pseudogene (RNU6-310P) is a processed pseudogene of the U6 small nuclear RNA (snRNA) gene family. U6 snRNAs are essential components of the spliceosome, but pseudogenes such as RNU6-310P do **not encode functional RNAs or proteins** and are generally considered non-functional “genomic fossils.” Like other snRNA-derived pseudogenes, RNU6-310P may have arisen via LINE retrotransposition events and lacks the capacity for typical biological or pharmacological targeting. However, some pseudogenes can influence gene regulation through antisense, siRNA, or competing endogenous RNA effects, particularly in disease contexts such as cancer, but there is no specific evidence that RNU6-310P has such regulatory activity[2][4][5]. \n**RNU6-310P is not a therapeutic target** or functional receptor, enzyme, transporter, or drug target, but is rather a genomic pseudogene with no known direct functional or clinical significance. There is no evidence of approved drugs, biomarkers, or safety concerns related to this entry.\n\n**Note:** This entry is problematic for structured therapeutic target databases as it refers to a *pseudogene*, not an active molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 310, pseudogene (RNU6-310P).